Study discovers molecular pathways for the development of mucormycosis

July 21, 2016, Los Angeles Biomedical Research Institute at Harbor

Research published today in the journal, Nature Communications, provides new insights into the evolution of Mucorales fungi, which cause a fatal infection in ever-increasing segments of patient population, and several molecular pathways that might be exploited as potential therapeutic or diagnostic targets.

Mucorales invades the cells of people with and causes the deadly infection, mucormycosis. The study, conducted by LA BioMed and the University of Maryland School of Medicine researchers, identified several pathways that are required for mucormycosis to develop in a patient.

"Our research opens the door for identifying and targeting the specific pathways that are required for the development of mucormycosis," said Ashraf S. Ibrahim, PhD, an LA BioMed lead researcher and a contributing author for the study. "The generated data could then be exploited to design novel strategies to pursue treatment, prevention and/or early diagnosis of mucormycosis."

The researchers reported on the sequencing of 30 isolates of Mucorales and the study of the transcriptomes of three most common causes of mucormycosis, in response to lung epithelial cells. They identified several pathways that are required for mucormycosis pathogenesis.

Those most at risk of mucormycosis are patients with uncontrolled diabetes ketoacidosis, other forms of metabolic acidosis, treatment with corticosteroids, solid organ or , neutropenia, trauma and burns, such as those suffered by wounded soldiers in Iraq and Afghanistan, malignant hematological disorders and deferoxamine therapy in patients receiving hemodialysis.

Cutaneous necrotizing soft tissue mucormycosis outbreaks in otherwise healthy individuals have also been known to follow natural disasters, as evidenced by the Apophysomyces infections, usually associated with trauma, following the tsunami that devastated Indonesia in 2004 and the tornadoes that occurred in Joplin, MO in June 2011.

"There are no vaccines or effective therapies available today to halt the highly fatal mucormycosis infection," Dr. Ibrahim said. "There is an urgent need for additional research to develop strategies to protect patients with weakened immune systems."

Explore further: New research offers hope for vaccine and therapies for deadly infections

More information: Nature Communications, DOI: 10.1038/NCOMMS12218

Related Stories

New research offers hope for vaccine and therapies for deadly infections

December 20, 2013
Mucormycosis is a deadly infection that strikes people with weakened immune systems when certain types of fungi, called Mucorales, invade the patients' cells. A novel protein on the surface of the Mucorales cells, called ...

New investigational drug holds promise for combatting deadly mucormycosis infections

February 6, 2014
With very few treatment options available to fight deadly mucormycosis infections, a new Los Angeles Biomedical Research Institute (LA BioMed) study holds hope for adding to the arsenal of therapies physicians have to combat ...

Baking soda could prevent deadly fungal infections in diabetic ketoacidosis

May 9, 2016
Patients with diabetic ketoacidosis (DKA) face a much higher risk of succumbing to a deadly fungal infection, known as mucormycosis, than healthy patients. A new study suggests a simple treatment of sodium bicarbonate, or ...

Flesh-eating fungal infection can follow natural disasters, study finds

December 6, 2012
(HealthDay)—After a natural disaster, doctors should be on the lookout for outbreaks of a rare but deadly "flesh-eating" fungal infection, researchers at the U.S. Centers for Disease Control and Prevention reported Wednesday.

Fungus responsible for five deaths in the wake of massive tornado

December 14, 2012
A fast growing, flesh-eating fungus killed 5 people following a massive tornado that devastated Joplin, Mo., according to two new studies based on genomic sequencing by the Translational Genomics Research Institute (TGen) ...

Recommended for you

Infants born to obese mothers risk developing liver disease, obesity

November 16, 2018
Infant gut microbes altered by their mother's obesity can cause inflammation and other major changes within the baby, increasing the risk of obesity and non-alcoholic fatty liver disease later in life, according to researchers ...

New study shows NKT cell subsets play a large role in the advancement of NAFLD

November 16, 2018
Since 2015 it has been known that the gut microbiota could have a direct impact on nonalcoholic fatty liver disease (NAFLD), which affects up to 12% of adults and is a leading cause of chronic liver disease. In the November ...

Antibiotic prescribing influenced by team dynamics within hospitals

November 15, 2018
Antibiotic prescribing by doctors is influenced by team dynamics and cultures within hospitals.

Discovery suggests new route to fight infection, disease

November 14, 2018
New research reveals how a single protein interferes with the immune system when exposed to the bacterium that causes Legionnaires' disease, findings that could have broad implications for development of medicines to fight ...

Zika may hijack mother-fetus immunity route

November 14, 2018
To cross the placenta, Zika virus may hijack the route by which acquired immunity is transferred from mother to fetus, new research suggests.

New research aims to help improve uptake of hepatitis C testing

November 14, 2018
New research published in Scientific Reports shows persisting fears about HIV infection may impact testing uptake for the hepatitis C Virus (HCV).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.